PAFSC’s 2nd Committee Recommends Approval for CMIC’s Acute Porphyria Treatment

February 27, 2013
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs, an advisory organ to the health minister, discussed and recommended approval for two products, including CMIC Holdings’ acute porphyria treatment Normosang Drip Infusion 250 mg (hemin), at a...read more